These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 33982318)
1. Recurrent injection-site reactions after incorrect subcutaneous administration of a COVID-19 vaccine. Gyldenløve M; Skov L; Hansen CB; Garred P J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):e545-e546. PubMed ID: 33982318 [No Abstract] [Full Text] [Related]
2. Early atypical injection-site reactions to COVID-19 vaccine: a case series. Vaccaro M; Bertino L; Squeri R; Genovese C; Isola S; Spatari G; Spina E; Cutroneo P J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):e24-e26. PubMed ID: 34547113 [No Abstract] [Full Text] [Related]
3. Inadvertent subcutaneous injection of COVID-19 vaccine. Ng JY Postgrad Med J; 2021 Jun; 97(1148):400. PubMed ID: 33589486 [No Abstract] [Full Text] [Related]
4. Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine (Moderna) in a Cohort of Hospital Employees. Jacobson MA; Zakaria A; Maung Z; Hart C; McCalmont TH; Fassett M; Amerson E Clin Infect Dis; 2022 Mar; 74(4):591-596. PubMed ID: 34086881 [TBL] [Abstract][Full Text] [Related]
5. COVID-19 Vaccine Reactions in Dermatology: "Filling" in the Gaps. Rice SM; Ferree SD; Kourosh AS Cutis; 2021 Jun; 107(6):288-290. PubMed ID: 34314309 [No Abstract] [Full Text] [Related]
7. "COVID Arm": Very delayed large injection site reactions to mRNA COVID-19 vaccines. Ramos CL; Kelso JM J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2480-2481. PubMed ID: 33864927 [No Abstract] [Full Text] [Related]
8. COVID Arm After Moderna Booster in Healthcare Worker: A Case Report. Saifuddin A; Koesnoe S; Kurniati N; Sirait S; Arisanty R; Yunihastuti E Acta Med Indones; 2021 Jul; 53(3):326-330. PubMed ID: 34611073 [TBL] [Abstract][Full Text] [Related]
9. Effect of gentle exercises on injection site reaction after Covid-19 vaccination. A case report. Kalia V J Bodyw Mov Ther; 2021 Oct; 28():527-529. PubMed ID: 34776189 [TBL] [Abstract][Full Text] [Related]
10. Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series. Johnston MS; Galan A; Watsky KL; Little AJ JAMA Dermatol; 2021 Jun; 157(6):716-720. PubMed ID: 33978670 [TBL] [Abstract][Full Text] [Related]
11. COVID Arm: Delayed Hypersensitivity Reactions to SARS-CoV-2 Vaccines Misdiagnosed as Cellulitis. Lindgren AL; Austin AH; Welsh KM J Prim Care Community Health; 2021; 12():21501327211024431. PubMed ID: 34120504 [TBL] [Abstract][Full Text] [Related]
12. Cutaneous adverse reactions to coronavirus vaccines: A Saudi nationwide study. Bukhari AE; Almutlq MM; Bin Dakhil AA; Alhetheli GI; Alfouzan SK; Alqahtani MA; Aljalfan AA; Almutawa MA; Alsubaie FS; Madani AN Dermatol Ther; 2022 Jun; 35(6):e15452. PubMed ID: 35293657 [TBL] [Abstract][Full Text] [Related]
13. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336 [TBL] [Abstract][Full Text] [Related]
14. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials. Xia S; Duan K; Zhang Y; Zhao D; Zhang H; Xie Z; Li X; Peng C; Zhang Y; Zhang W; Yang Y; Chen W; Gao X; You W; Wang X; Wang Z; Shi Z; Wang Y; Yang X; Zhang L; Huang L; Wang Q; Lu J; Yang Y; Guo J; Zhou W; Wan X; Wu C; Wang W; Huang S; Du J; Meng Z; Pan A; Yuan Z; Shen S; Guo W; Yang X JAMA; 2020 Sep; 324(10):951-960. PubMed ID: 32789505 [TBL] [Abstract][Full Text] [Related]
15. Anaphylaxis is a rare reaction in COVID-19 vaccination. Bellomo RG; Gallenga CE; Caraffa A; Tetè G; Ronconi G; Conti P J Biol Regul Homeost Agents; 2021; 35(3):839-842. PubMed ID: 34105336 [TBL] [Abstract][Full Text] [Related]
16. Hypersensitivity reactions to vaccines in children: from measles to SARS-CoV-2. Caffarelli C; Liotti L; Bianchi A; Bottau P; Caimmi S; Crisafulli G; Franceschini F; Paglialunga C; Saretta F; Mori F Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27(Suppl 27):58-60. PubMed ID: 35080320 [TBL] [Abstract][Full Text] [Related]
17. Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura. Chanut M; Jaidi R; Kohn M; Grange T; Brones C; Lombion N; Rousselot P; Longval T Platelets; 2022 May; 33(4):652-653. PubMed ID: 35225144 [TBL] [Abstract][Full Text] [Related]
18. Localized lipoatrophy and inadvertent subcutaneous administration of a COVID-19 vaccine. Cook IF Hum Vaccin Immunother; 2022 Nov; 18(5):2042136. PubMed ID: 35258436 [TBL] [Abstract][Full Text] [Related]
19. Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2. Sprute R; Schumacher S; Pauls M; Pauls W; Cornely OA Drugs R D; 2021 Dec; 21(4):371-374. PubMed ID: 34351606 [TBL] [Abstract][Full Text] [Related]
20. Determining the frequency of serious adverse reactions of inactive SARS-COV-2 vaccine. Kaya F; Pirincci E Work; 2021; 69(3):735-739. PubMed ID: 34219684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]